In a Letter to the Editor of the New York Times, Politico founder Martin Tolchin disagreed with an editorial calling for an investigation into Tara Reade’s sexual assault allegations of Joe Biden. Tolchin said he wants “a coronation of Joe Biden,” not an investigation into the former Senate aide’s rape allegations.
“I don’t want an investigation. I want a coronation of Joe Biden. Would he make a great president? Unlikely. Would he make a good president? Good enough. Would he make a better president than the present occupant? Absolutely,” Tolchin wrote.
Tolchin continued to say he was not interested in justice for Reade. “I don’t want justice, whatever that may be. I want a win, the removal of Donald Trump from office, and Mr. Biden is our best chance,” Tolchin said. “Suppose an investigation reveals damaging information concerning his relationship with Tara Reade or something else, and Mr. Biden loses the nomination to Senator Bernie Sanders or someone else with a minimal chance of defeating Mr. Trump. Should we really risk the possibility?” Tolchin wrote.
Tolchin worked for the New York Times for 40 years, founded The Hill, and helped launch Politico. He isn’t even trying to seem balanced or unbiased anymore, which anyone who has ever read Politico knows, but this is blantant.
I guess for Biden supporters, #MeToo’s standard of #BelieveAllWomen is out if it may hurt a Democrat trying to grab the White House.
COVID-19 Researcher Shot Dead in Murder Suicide
A medical researcher said to be on the “verge of making very significant” coronavirus findings was found shot to death over the weekend in Pennsylvania, officials said. 37-year old Bing Liu who was a researcher for the University of Pittsburgh School of Medicine, was found dead Saturday inside his townhome in Ross Township shot in the head and neck, according to the Allegheny County Medical Examiner.
An hour after Dr. Liu’s body was discovered, a second person, Hao Gu, 46, was found dead inside a car. Hao Gu, the apparent shooter, shot Dr. Liu in his townhome, then got into his car parked at the complex and killed himself, authorities said.
The two men knew each other, authorities said, but a motive for the shooting remains under investigation. Nothing was stolen from the townhouse and there was no forced entry, authorities said. A motive for the killings remained unknown, and the relationship between the men was also unclear.
Liu, who earned a PhD in computational science from the National University of Singapore, worked as a postdoctoral fellow at Carnegie Mellon University before becoming a research associate at the University of Pittsburgh School of Medicine.
In a statement, the University of Pittsburgh described him as an excellent mentor and prolific researcher who had co-authored more than 30 papers. His work focused on systems biology.
“Bing was on the verge of making very significant findings toward understanding the cellular mechanisms that underlie SARS-CoV-2 infection (Which is COVID-19) and the cellular basis of the following complications,” the school said. “We will make an effort to complete what he started in an effort to pay homage to his scientific excellence.”
Does this Murder/Suicide sound suspicious to you? Reply to this email and let us know!
Silver Mining Stocks Might Have Some Upside
Much more than “gold’s cheaper cousin,” silver is an industrial metal. If you’re looking to capitalize on a rising silver price, a position in Pan American Silver (NASDAQ:PAAS) stock offers a highly favorable risk-reward profile. Why a miner of actual sivler? Silver is known for being more volatile than gold, so trading silver futures might not be the best choice. The price moves in both directions can be swift and sizable.
Pan American Silver could be a stock that checks all of the right boxes. Given the company’s history of robust production and low cost of getting silver out of the ground, Pan American Silver is could be a solid choice.
If you search through the vast sea of mining companies, you’ll notice that many of them are focused on gold while silver is just an afterthought. In contrast, Pan American is potentially sitting on 557.2 million ounces of silver reserves. Furthermore, the company claims 25.9 million ounces of silver production. Pan American does have interests in gold, copper, and other metals besides silver. However, the company stays focused on silver which converts to low cost production.
One way to measure this is through all-in sustaining cost, or AISC. This is a simplified gauge of how much it costs the company to get an ounce of silver out of the ground. In fiscal year 2019, Pan American’s consolidated silver basis AISC was a remarkably low $4.44 for each silver ounce sold. As a basis of comparison, the spot price of silver stayed close to $15 per ounce throughout the month of April. This also shows why a stock can be profitable even though silver futures maybe falling. The stock will take a hit if silver prices fall, but there are other aspects of the business they can manage like labor and debt.
Silver is a commodity that investors shouldn’t ignore. The potential medical uses during the coronavirus pandemic could enhance silver’s value, although this I likely to be very small. A larger affect could be an infrastructure bill to help the economy. A higher probablity given the virus slowdown.
Allogene Therapeutics Inc (NASDAQ: ALLO)
Investors are always looking for stocks that are poised to beat at earnings season and Allogene Therapeutics, Inc. ALLO may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
That is because Allogene Therapeutics is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for ALLO in this report.
In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 56 cents per share for ALLO, compared to a broader Zacks Consensus Estimate at a loss of 57 cents per share. This suggests that analysts have very recently bumped up their estimates for ALLO.
This might be a decent stock to look at pre-earnings. Clearly, recent earnings estimate revisions suggest that good things are ahead for Allogene Therapeutics, and that a beat might be in the cards for the upcoming report.
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Reply to this email and let us know, do you think it’s too late to get into biotech? Or is there still upside left?
Rowlf, The Big Brown Dog
There’s just nothing like a way too big, way too loving dog.
The two-year-old Newfoundland-poodle (a Newfypoo) mix named Rowlf is exactly that, and the pup just isn’t aware of his giant size.
Rowlf has been with the Pankhurst family since the summer of 2018 and in that time has grown from a tiny puppy to a massive, six-foot tall (still puppy) dog when standing on his hind legs, weighing more than 100lbs. Despite his massive growth spurt, the Newfypoo still attempts to sit on his owner, Craig’s lap, even though he’s far too big.
Craig, a dad-of-two from Thurstaston, UK said: “He’s a legend – he’s huge. He doesn’t really know his own size, he thinks he’s a little puppy or the same size as the bulldogs. “He’s very funny. Rowlf will go to get on a normal-size [dog] bed and just sit down on it. He is so much bigger than the other two. He’s not clumsy, but he does like to lay on things and if that is a tiny bed, he tries to make himself as small as possible.”
He continued to say: “He occasionally tries to hop up on to my lap. It’s quite amusing when he does. He thinks he’s a lapdog. But he’s so gentle and surprisingly easy to deal with in the house – apart from if he gets wet, comes inside and shakes. Then everything gets sprayed.”
And while having Rowlf around has sometimes caused chaos for the family, it’s also made the biggest difference. Two years ago Craig suffered a stroke which left him unable to walk without a limp and feeling very low. Craig said: “Having daily exercise through walking improved my coordination, developed my strength in my left side and I was able to increase the speed I could walk over time.
Rowlf has now become the ‘ambassadog’ for his charity, A Stroke of Luck. “Two years on, I’m in a much better physical and mental place thanks, in part, to having Rowlf. He’s absolutely helped me. Being a dog that needs exercising, on the days where I have suffered with depression and anxiety, he has forced me to go out. “Now his role is to bring happiness and light to the charity and anyone who engages with it.” We love you too, Rowlf